Duo-Wu Zou

Prof. Duo-Wu Zou


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
JZJiulong Zhao
Jiulong Zhao
WGWei Gao
Wei Gao
Xiaojun CaiXiaojun Cai
Xiaojun Cai
JXJiajia Xu
Jiajia Xu
DZDuo-Wu Zou
Duo-Wu Zou
Yuanyi ZhengYuanyi Zheng
Yuanyi Zheng
The overproduction of reactive oxygen species (ROS) is linked to inflammatory bowel disease (IBD) and causes oxidative damage to DNA, proteins, and lipids. These ROS promote the initiation and progression of ulcerative colitis (UC). This study proposes a unique concept of nanomaterials with intrinsic enzyme-like activity (nanozymes) to mediate catalytic nanotherapy for IBD.

27 July 2022 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
XZXiangyu Zhao
Xiangyu Zhao
JCJiayin Chen
Jiayin Chen
HSHongxiang Sun
Hongxiang Sun
YZYao Zhang
Yao Zhang
DZDuo-Wu Zou
Duo-Wu Zou
Fibrosis is a pathological feature of a variety of chronic inflammatory diseases that can affect almost all organs, which can cause severe consequences and even lead to death. Fibrosis is characterized by the excessive accumulation of extracellular matrix (ECM) due to disruption of the balance between ECM production and degradation. Although overabundance of ECM proteins has long been the focus of studies on fibrosis, another facet of the problem—impaired degradation of the ECM—is gaining increasing attention. Matrix metalloproteinase (MMP) and the tissue inhibitor of metalloproteinase (TIMP) system is the main molecular system contributing to ECM degradation, and macrophages are the major regulators of ECM. However, the relationship among macrophages, the MMP/TIMP system and the ECM is not fully understood in the context of fibrosis. Here, we discuss in detail the role played by the ECM in the development of fibrosis and highlight the macrophage-MMP-ECM interaction that is involved in fibrogenesis and may be a potential therapeutic target for fibrosis.

20 July 2018 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JZJiulong Zhao
Jiulong Zhao
Xiaojun CaiXiaojun Cai
Xiaojun Cai
WGWei Gao
Wei Gao
LZLinlin Zhang
Linlin Zhang
DZDuo-Wu Zou
Duo-Wu Zou
Hangrong ChenHangrong Chen
Hangrong Chen

1 August 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
Shige WangShige Wang
Shige Wang
JZJiulong Zhao
Jiulong Zhao
HYHailun Yang
Hailun Yang
CWChenyao Wu
Chenyao Wu
FHFei Hu
Fei Hu
MHMingxian Huang
Mingxian Huang

18 July 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YZYao Zhang
Yao Zhang
JWJiaxin Wang
Jiaxin Wang
HSHongxiang Sun
Hongxiang Sun
ZXZhenzhen Xun
Zhenzhen Xun
ZHZirui He
Zirui He
BSBing Su
Bing Su
Intestinal fibrosis, a severe complication of Crohn’s disease (CD), is characterized by excessive extracellular matrix (ECM) deposition and induces intestinal strictures, but there are no effective antifibrosis drugs available for clinical application. We performed single-cell RNA sequencing (scRNA-Seq) of fibrotic and nonfibrotic ileal tissues from patients with CD with intestinal obstruction. Analysis revealed mesenchymal stromal cells (MSCs) as the major producers of ECM and the increased infiltration of its subset FAP + fibroblasts in fibrotic sites, which was confirmed by immunofluorescence and flow cytometry. Single-cell transcriptomic profiling of chronic dextran sulfate sodium salt murine colitis model revealed that CD81 + Pi16 – fibroblasts exhibited transcriptomic and functional similarities to human FAP + fibroblasts. Consistently, FAP + fibroblasts were identified as the key subtype with the highest level of ECM production in fibrotic intestines. Furthermore, specific knockout or pharmacological inhibition of TWIST1, which was highly expressed by FAP + fibroblasts, could significantly ameliorate fibrosis in mice. In addition, TWIST1 expression was induced by CXCL9 + macrophages enriched in fibrotic tissues via IL-1β and TGF-β signal. These findings suggest the inhibition of TWIST1 as a promising strategy for CD fibrosis treatment.

1 January 2020 in Pancreatology
Verified
Journal Article
Closed access
CZChun-Hua Zhou
Chun-Hua Zhou
YMYu-Ting Meng
Yu-Ting Meng
JXJia-Jia Xu
Jia-Jia Xu
XFXue Fang
Xue Fang
JZJiu-Long Zhao
Jiu-Long Zhao
DZDuo-Wu Zou
Duo-Wu Zou